MedDRA MSSO

MedDRA User Group Meetings

The objective of the User Group meetings is to achieve effective two-way communication concerning the use of MedDRA, provide a forum for the exchange of best practices and lessons learned, provide feedback on the quality and effectiveness of MSSO services, and identify new services that might be necessary or helpful to subscribers. In addition, the User Group meetings provide an opportunity for individuals to network with other professionals in the pharmacovigilance community.

The MSSO holds two User Group meetings per year--one in Europe, and one in the United States. The MedDRA Japanese Maintenance Organization (JMO) holds the JMO User Group Meeting in Japan. For detailed information, please contact the JMO at helpdesk.jmo@sjp.or.jp.


MedDRA User Group Meeting - Washington, D. C. USA

Walter E. Washington Convention Center
Room 207A
Washington, D.C. USA
17 June 2010, 12:30 – 5:00pm

Agenda:

Registration:
On-Line Form

Registration deadline: 10 June 2010




MedDRA User Group Meeting - Beijing, China

Where: 中工大厦, 二楼“多功能厅”, 北京市海淀区增光路45号

20 May 2010, 16:30 – 17:00pm

No registration is needed

    Agenda

    Welcome and MSSO Update                              Anna Zhao-Wong, MSSO

    MedDRA在CTDMS和EDC中的即时应用          王秀兰. DMS-Pharma

    MedDRA使用体会                                                 Catherine Xie, Pfizer

    The challenges of using MedDRA
    in clinical practice
                                                     蘇琤婷, Protech Pharmaservices Corporation

     



MedDRA User Group Meeting - Monte Carlo, Monaco

Novotel Monte Carlo

11 March 2010

Agenda:

Introduction and Welcome                    Pat Revelle
ICH Initiatives related to ICSR              Sabine Brosch
    and IDMP
MedDRA Changes: Proactivity             Jane Knight and Patricia Mozzicato
    or Reactivity?     

MedDRA EU Informal User Group Meeting

There will be a MedDRA EU Informal User Group Meeting in the same room, following the MedDRA User Group Meeting.

Agenda:

13.30     Welcome

13.40     Product Quality & Medication Error Terms: Identify issues for future MedDRA Term Selection: Points to Consider document - Christina Winter, GlaxoSmithKline & Laurence Trinh-La, Lundbeck

14.10     MedDRA in a CRO's world: Challenges and experiences - Petra Barth, PRA International

14.40     Break

15.00     MedDRA Versioning - Hilary Vass, Astra Zeneca

15.30     CTCAE version 4: Experiences post-release - Carol-Ann Wilson, Bayer Healthcare

16.00     Meeting Close


EU Informal User Group

Chinese MedDRA User Group (中华MedDRA用户小组)

User Group Meeting Archive

mssohelp@ngc.com
Copyright © 2010 Northrop Grumman Corporation
All Rights Reserved
Updated: 2010-08-20

MedDRA MSSO
Toll Free International: +1 877.258.8280
Direct: +1 703.272.5505